Currently, CervoMed Inc [CRVO] is trading at $9.98, up 9.07%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CRVO shares have gain 12.77% over the last week, with a monthly amount glided 366.36%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CervoMed Inc [NASDAQ: CRVO] stock has seen the most recent analyst activity on March 13, 2025, when Chardan Capital Markets upgraded its rating to a Buy but kept the price target unchanged to $14 for it. Previously, H.C. Wainwright downgraded its rating to Neutral on December 17, 2024. On December 11, 2024, downgrade downgraded it’s rating to Underweight. Chardan Capital Markets downgraded its rating to a Neutral. D. Boral Capital downgraded its rating to a Hold. ROTH MKM started tracking with a Buy rating for this stock on December 06, 2024, and assigned it a price target of $45. In a note dated December 05, 2024, H.C. Wainwright initiated an Buy rating and provided a target price of $42 on this stock.
This stock has fluctuated between a low of $1.80 and a high of $25.92 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $17.31 within the next 12 months. CervoMed Inc [NASDAQ: CRVO] shares were valued at $9.98 at the most recent close of the market. An investor can expect a potential return of 73.45% based on the average CRVO price forecast.
Analyzing the CRVO fundamentals
Trailing Twelve Months sales for CervoMed Inc [NASDAQ:CRVO] were 9.74M which represents -13.19% decline. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -3.23%, Pretax Profit Margin comes in at -2.89%, and Net Profit Margin reading is -2.89%. To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.46 and Total Capital is -0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.81 points at the first support level, and at 7.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.97, and for the 2nd resistance point, it is at 11.97.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CervoMed Inc [NASDAQ:CRVO] is 11.11. As well, the Quick Ratio is 11.11, while the Cash Ratio is 2.32. Considering the valuation of this stock, the price to sales ratio is 8.92, the price to book ratio is 2.22.
Transactions by insiders
Recent insider trading involved ELDER WILLIAM ROBERT, CFO & GC, that happened on Aug 27 ’24 when 1000.0 shares were purchased.
